HCPCS Level II › G
HCPCS Level II codes starting with G
2,011 codes, page 11 of 21. Every code ever valid for billing is listed, including those now retired.
| Code | Description | Status |
|---|---|---|
| G8864 | Pneumococcal vaccine administered or previously received | Valid |
| G8865 | Documentation of medical reason(s) for not administering or previously receiving pneumococcal vaccine (e.g., patient allergic reaction, potential adverse drug reaction) | Valid |
| G8866 | Documentation of patient reason(s) for not administering or previously receiving pneumococcal vaccine (e.g., patient refusal) | Valid |
| G8867 | Pneumococcal vaccine not administered or previously received, reason not given | Valid |
| G8868 | Patients receiving a first course of anti-tnf therapy through FY2026 | Terminated |
| G8869 | Patient has documented immunity to hepatitis b and initiating anti-tnf therapy | Valid |
| G8870 | Hepatitis b vaccine injection administered or previously received and is receiving a first course of anti-tnf therapy through FY2026 | Terminated |
| G8871 | Patient not receiving a first course of anti-tnf therapy through FY2026 | Terminated |
| G8872 | Excised tissue evaluated by imaging intraoperatively to confirm successful inclusion of targeted lesion through FY2026 | Terminated |
| G8873 | Patients with needle localization specimens which are not amenable to intraoperative imaging such as mri needle wire localization, or targets which are tentatively identified on mammogram or ultrasound which do not contain a biopsy marker but which can be verified on intraoperative inspection or pathology (e.g., needle biopsy site where the biopsy marker is remote from the actual biopsy site) through FY2026 | Terminated |
| G8874 | Excised tissue not evaluated by imaging intraoperatively to confirm successful inclusion of targeted lesion through FY2026 | Terminated |
| G8875 | Clinician diagnosed breast cancer preoperatively by a minimally invasive biopsy method | Valid |
| G8876 | Documentation of reason(s) for not performing minimally invasive biopsy to diagnose breast cancer preoperatively (e.g., lesion too close to skin, implant, chest wall, etc., lesion could not be adequately visualized for needle biopsy, patient condition prevents needle biopsy [weight, breast thickness, etc.], duct excision without imaging abnormality, prophylactic mastectomy, reduction mammoplasty, excisional biopsy performed by another physician) | Valid |
| G8877 | Clinician did not attempt to achieve the diagnosis of breast cancer preoperatively by a minimally invasive biopsy method, reason not given | Valid |
| G8878 | Sentinel lymph node biopsy procedure performed | Valid |
| G8879 | Clinically node negative (t1n0m0 or t2n0m0) invasive breast cancer through FY2026 | Terminated |
| G8880 | Documentation of reason(s) sentinel lymph node biopsy not performed (e.g., reasons could include but not limited to; non-invasive cancer, incidental discovery of breast cancer on prophylactic mastectomy, incidental discovery of breast cancer on reduction mammoplasty, pre-operative biopsy proven lymph node (ln) metastases, inflammatory carcinoma, stage 3 locally advanced cancer, recurrent invasive breast cancer, clinically node positive after neoadjuvant systemic therapy, patient refusal after informed consent, patient with significant age, comorbidities, or limited life expectancy and favorable tumor; adjuvant systemic therapy unlikely to change) | Valid |
| G8881 | Stage of breast cancer is greater than t1n0m0 or t2n0m0 | Valid |
| G8882 | Sentinel lymph node biopsy procedure not performed, reason not given | Valid |
| G8883 | Biopsy results reviewed, communicated, tracked and documented through FY2026 | Terminated |
| G8884 | Clinician documented reason that patient's biopsy results were not reviewed through FY2026 | Terminated |
| G8885 | Biopsy results not reviewed, communicated, tracked or documented through FY2026 | Terminated |
| G8886 | Most recent blood pressure under control through FY2026 | Terminated |
| G8887 | Documentation of medical reason(s) for most recent blood pressure not being under control (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate) through FY2026 | Terminated |
| G8888 | Most recent blood pressure not under control, results documented and reviewed through FY2026 | Terminated |
| G8889 | No documentation of blood pressure measurement, reason not given through FY2026 | Terminated |
| G8890 | Most recent ldl-c under control, results documented and reviewed through FY2026 | Terminated |
| G8891 | Documentation of medical reason(s) for most recent ldl-c not under control (e.g., patients with palliative goals for whom treatment of hypertension with standard treatment goals is not clinically appropriate) through FY2026 | Terminated |
| G8892 | Documentation of medical reason(s) for not performing ldl-c test (e.g. patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate) through FY2026 | Terminated |
| G8893 | Most recent ldl-c not under control, results documented and reviewed through FY2026 | Terminated |
| G8894 | Ldl-c not performed, reason not given through FY2026 | Terminated |
| G8895 | Oral aspirin or other antithrombotic therapy prescribed through FY2026 | Terminated |
| G8896 | Documentation of medical reason(s) for not prescribing oral aspirin or other antithrombotic therapy (e.g., patient documented to be low risk or patient with terminal illness or treatment of hypertension with standard treatment goals is not clinically appropriate, or for whom risk of aspirin or other antithrombotic therapy exceeds potential benefits such as for individuals whose blood pressure is poorly controlled) through FY2026 | Terminated |
| G8897 | Oral aspirin or other antithrombotic therapy was not prescribed, reason not given through FY2026 | Terminated |
| G8898 | I intend to report the chronic obstructive pulmonary disease (copd) measures group through FY2026 | Terminated |
| G8899 | I intend to report the inflammatory bowel disease (ibd) measures group through FY2026 | Terminated |
| G8900 | I intend to report the sleep apnea measures group through FY2026 | Terminated |
| G8902 | I intend to report the dementia measures group through FY2026 | Terminated |
| G8903 | I intend to report the parkinson's disease measures group through FY2026 | Terminated |
| G8904 | I intend to report the hypertension (htn) measures group through FY2026 | Terminated |
| G8905 | I intend to report the cardiovascular prevention measures group through FY2026 | Terminated |
| G8906 | I intend to report the cataract measures group through FY2026 | Terminated |
| G8907 | Patient documented not to have experienced any of the following events: a burn prior to discharge; a fall within the facility; wrong site/side/patient/procedure/implant event; or a hospital transfer or hospital admission upon discharge from the facility | Valid |
| G8908 | Patient documented to have received a burn prior to discharge | Valid |
| G8909 | Patient documented not to have received a burn prior to discharge | Valid |
| G8910 | Patient documented to have experienced a fall within asc | Valid |
| G8911 | Patient documented not to have experienced a fall within ambulatory surgical center | Valid |
| G8912 | Patient documented to have experienced a wrong site, wrong side, wrong patient, wrong procedure or wrong implant event | Valid |
| G8913 | Patient documented not to have experienced a wrong site, wrong side, wrong patient, wrong procedure or wrong implant event | Valid |
| G8914 | Patient documented to have experienced a hospital transfer or hospital admission upon discharge from asc | Valid |
| G8915 | Patient documented not to have experienced a hospital transfer or hospital admission upon discharge from asc | Valid |
| G8916 | Patient with preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis, antibiotic initiated on time | Valid |
| G8917 | Patient with preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis, antibiotic not initiated on time | Valid |
| G8918 | Patient without preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis | Valid |
| G8923 | Current or prior left ventricular ejection fraction (lvef) <= 40% or documentation of moderately or severely depressed left ventricular systolic function | Valid |
| G8924 | Spirometry results documented (fev1/fvc < 70%) | Valid |
| G8925 | Spirometry test results demonstrate fev1 >= 60% fev1/fvc >= 70%, predicted or patient does not have copd symptoms through FY2026 | Terminated |
| G8926 | Spirometry test not performed or documented, reason not given through FY2026 | Terminated |
| G8927 | Adjuvant chemotherapy referred, prescribed or previously received for ajcc stage iii, colon cancer through FY2026 | Terminated |
| G8928 | Adjuvant chemotherapy not prescribed or previously received, for documented reasons (e.g., medical co-morbidities, diagnosis date more than 5 years prior to the current visit date, patient's diagnosis date is within 120 days of the end of the 12 month reporting period, patient's cancer has metastasized, medical contraindication/allergy, poor performance status, other medical reasons, patient refusal, other patient reasons, patient is currently enrolled in a clinical trial that precludes prescription of chemotherapy, other system reasons) through FY2026 | Terminated |
| G8929 | Adjuvant chemotherapy not prescribed or previously received, reason not given through FY2026 | Terminated |
| G8930 | Assessment of depression severity at the initial evaluation through FY2026 | Terminated |
| G8931 | Assessment of depression severity not documented, reason not given through FY2026 | Terminated |
| G8932 | Suicide risk assessed at the initial evaluation through FY2026 | Terminated |
| G8933 | Suicide risk not assessed at the initial evaluation, reason not given through FY2026 | Terminated |
| G8934 | Current or prior left ventricular ejection fraction (lvef) <=40% or documentation of moderately or severely depressed left ventricular systolic function | Valid |
| G8935 | Clinician prescribed angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy | Valid |
| G8936 | Clinician documented that patient was not an eligible candidate for angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy (eg, allergy, intolerance, pregnancy, renal failure due to ace inhibitor, diseases of the aortic or mitral valve, other medical reasons) or (eg, patient declined, other patient reasons) | Valid |
| G8937 | Clinician did not prescribe angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy, reason not given | Valid |
| G8938 | Bmi is documented as being outside of normal parameters, follow-up plan is not documented, documentation the patient is not eligible through FY2026 | Terminated |
| G8939 | Pain assessment documented as positive, follow-up plan not documented, documentation the patient is not eligible at the time of the encounter through FY2026 | Terminated |
| G8940 | Screening for depression documented as positive, a follow-up plan not completed, documented reason through FY2026 | Terminated |
| G8941 | Elder maltreatment screen documented as positive, follow-up plan not documented, documentation the patient is not eligible for follow-up plan at the time of the encounter through FY2026 | Terminated |
| G8942 | Functional outcome assessment using a standardized tool is documented within the previous 30 days and a care plan, based on identified deficiencies is documented within two days of the functional outcome assessment | Valid |
| G8943 | Ldl-c result not present or not within 12 months prior through FY2026 | Terminated |
| G8944 | Ajcc melanoma cancer stage 0 through iic melanoma | Valid |
| G8946 | Minimally invasive biopsy method attempted but not diagnostic of breast cancer (e.g., high risk lesion of breast such as atypical ductal hyperplasia, lobular neoplasia, atypical lobular hyperplasia, lobular carcinoma in situ, atypical columnar hyperplasia, flat epithelial atypia, radial scar, complex sclerosing lesion, papillary lesion, or any lesion with spindle cells) | Valid |
| G8947 | One or more neuropsychiatric symptoms through FY2026 | Terminated |
| G8948 | No neuropsychiatric symptoms through FY2026 | Terminated |
| G8949 | Documentation of patient reason(s) for patient not receiving counseling for diet and physical activity (e.g., patient is not willing to discuss diet or exercise interventions to help control blood pressure, or the patient said he/she refused to make these changes) through FY2026 | Terminated |
| G8950 | Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented | Valid |
| G8951 | Pre-hypertensive or hypertensive blood pressure reading documented, indicated follow-up not documented, documentation the patient is not eligible through FY2026 | Terminated |
| G8952 | Elevated or hypertensive blood pressure reading documented, indicated follow-up not documented, reason not given | Valid |
| G8953 | All quality actions for the applicable measures in the oncology measures group have been performed for this patient through FY2026 | Terminated |
| G8955 | Most recent assessment of adequacy of volume management documented | Valid |
| G8956 | Patient receiving maintenance hemodialysis in an outpatient dialysis facility | Valid |
| G8957 | Patient not receiving maintenance hemodialysis in an outpatient dialysis facility through FY2026 | Terminated |
| G8958 | Assessment of adequacy of volume management not documented, reason not given | Valid |
| G8959 | Clinician treating major depressive disorder communicates to clinician treating comorbid condition through FY2026 | Terminated |
| G8960 | Clinician treating major depressive disorder did not communicate to clinician treating comorbid condition, reason not given through FY2026 | Terminated |
| G8961 | Cardiac stress imaging test primarily performed on low-risk surgery patient for preoperative evaluation within 30 days preceding this surgery | Valid |
| G8962 | Cardiac stress imaging test performed on patient for any reason including those who did not have low risk surgery or test that was performed more than 30 days preceding low risk surgery | Valid |
| G8963 | Cardiac stress imaging performed primarily for monitoring of asymptomatic patient who had pci within 2 years through FY2026 | Terminated |
| G8964 | Cardiac stress imaging test performed primarily for any other reason than monitoring of asymptomatic patient who had pci within 2 years (e.g., symptomatic patient, patient greater than 2 years since pci, initial evaluation, etc) through FY2026 | Terminated |
| G8965 | Cardiac stress imaging test primarily performed on low chd risk patient for initial detection and risk assessment through FY2026 | Terminated |
| G8966 | Cardiac stress imaging test performed on symptomatic or higher than low chd risk patient or for any reason other than initial detection and risk assessment through FY2026 | Terminated |
| G8967 | Fda approved oral anticoagulant is prescribed | Valid |
| G8968 | Documentation of medical reason(s) for not prescribing an fda-approved anticoagulant (e.g., present or planned atrial appendage occlusion or ligation or patient being currently enrolled in a clinical trial related to af/atrial flutter treatment) | Valid |
| G8969 | Documentation of patient reason(s) for not prescribing an oral anticoagulant that is fda approved for the prevention of thromboembolism (e.g., patient preference for not receiving anticoagulation) | Valid |
| G8970 | No risk factors or one moderate risk factor for thromboembolism | Valid |